Opportunity timeline
In plain English
BARDA is seeking contractors to provide influenza vaccines, antigens, and adjuvants for pandemic preparedness, public health emergencies, and improved vaccine development. Contractors must supply qualified staff, materials, equipment, and facilities, with U.S. facilities preferred, and support FDA submissions and manufacturing readiness. Eligible offerors must hold a U.S. influenza vaccine license or have submitted a Biologics License Application for a seasonal or pandemic influenza vaccine.
About this opportunity
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to…
Time remaining
Closes Nov 20, 2026
Related Opportunities

DARPA Surgical Competition (DSC) Industry Day

Cryo-Electron Microscopy (Cryo-EM) Services

Human Hindbrain Organoid Functional Assay Services.

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

Study entitled “Malaria and vector borne disease surveillance in the Colombia/Venezuela border”
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-F4BE55

